Arcadia Biosciences Inc. (RKDA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Arcadia Biosciences Inc. (RKDA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

4.90

0.05 (1.03%)

At close: Jan 14, 2025, 3:59 PM

4.90

0.00%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	4.9
Market Cap	6.69M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-6.77
PE Ratio (ttm)	-0.72
Forward PE	n/a
Analyst	Buy

Ask	6.25
Volume	5,151
Avg. Volume (20D)	1,234,906
Open	4.75
Previous Close	4.85
Day's Range	4.71 - 4.93
52-Week Range	1.85 - 10.31
Beta	undefined

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, Californi...

[Show more]

Industry Agricultural Inputs

Sector Basic Materials

IPO Date May 15, 2015

Employees 21

Stock Exchange NASDAQ

Ticker Symbol RKDA

Website https://www.arcadiabio.com

Analyst Forecast

According to 1 analyst ratings, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 22.45% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Arcadia Biosciences Inc. is scheduled to release its earnings on Mar 27, 2025, during market hours.
Analysts project revenue of $1.15M, reflecting a -1.71% YoY shrinking and earnings per share of -0.5, making a -76.19% decrease YoY.

Why Price Moved

1 month ago · Source

+101.85%

Arcadia Biosciences shares are trading higher afte... Unlock content with Pro Subscription

2 months ago · Source

-7.88%

Arcadia Biosciences shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss reported on Tuesday.

News

1 month ago · businesswire.com

ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Arcadia Biosci...

1 month ago · zacks.com

Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%

RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder.

1 month ago · businesswire.com

Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Arcadia (NASDAQ: RKDA) for possible breaches of fiduciary duty and other violations of law in its transaction with Roosevelt Resources. Click her...

1 month ago · businesswire.com

RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Roosevelt Resources LP is fair to Arcadia ...

1 month ago · businesswire.com

Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when complet...

1 month ago · zacks.com

Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y

RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.

2 months ago · zacks.com

Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates

Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.

2 months ago · seekingalpha.com

Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Ex...

2 months ago · businesswire.com

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial ...

2 months ago · zacks.com

4 Agriculture - Products Stocks to Watch Despite Industry Concerns

The near-term outlook for the Zacks Agriculture - Products industry is uncertain due to low commodity prices and inflated costs. Investors should watch BG, WFG, HYFM and RKDA, which are braving the in...